Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Trials|January 11, 2014
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)Athimalaipet V Ramanan, Andrew D Dick, Diana Benton, et al.
Arthritis and Rheumatism|November 13, 2003
The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis familiesEmma M Ogilvie, Mark S Fife, Susan D Thompson, et al.
Arthritis and Rheumatism|September 29, 2011
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic featuresNicolino Ruperto, Pierre Quartier, Nico Wulffraat, et al.
The New England Journal of Medicine|April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic ArthritisAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Ophthalmology|October 19, 2018
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic ArthritisDyfrig A Hughes, Giovanna Culeddu, Catrin O Plumpton, et al.
Arthritis and Rheumatism|October 2, 2002
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosisEbun Aganna, Fabio Martinon, Philip N Hawkins, et al.
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Arthritis Care & Research|November 10, 2012
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritisYukiko Kimura, Jennifer E Weiss, Kathryn L Haroldson, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
Health Technology Assessment (Winchester, England)|April 30, 2019
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCTAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Pageof 6